Skip to main content
. 2019 Jan 10;12:211–219. doi: 10.2147/IDR.S188538

Figure 2.

Figure 2

Trends of drug resistance rates to first-line anti-TB drugs.

Notes: Trends of drug resistance rates for four first-line anti-TB drugs (rifampicin, isoniazid, streptomycin and ethambutol) and MDR-TB in new TB cases (A), previously treated TB cases (B) and total TB cases (C) at a major hospital in Guizhou Province of China during the study period 2008–2015.

Abbreviations: MDR, multidrug resistant; TB, tuberculosis.